SCHEMBL7336485

SCHEMBL7336485

CC(COC(N)=O)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP1A2 P05177 4/20 0.46
CYP2D6 P10635 1/20 0.46
PKM P14618 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 4/20 0.46
LMNA P02545 3/20 0.46
CYP3A4 P08684 3/20 0.44
ALDH1A1 P00352 3/20 0.43
TSHR P16473 3/20 0.41
ABCB11 O95342 1/20 0.41
ESR1 P03372 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2C9 P11712 1/20 0.41
PDE4A P27815 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRK1 P41145 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17266326 0.86 TSHR (0.49) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL12836125 0.82 CYP3A4 (0.47) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL476473 0.81 CYP1A2 (0.46) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL8392046 0.81 CYP1A2 (0.50) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL29137043 0.81 SMN1; SMN2 (0.44) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL8392970 0.81 CYP1A2 (0.50) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL8397236 0.80 CYP1A2 (0.53) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL16561481 0.79 CYP3A4 (0.45) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL13512389 0.76 TSHR (0.46) SMN1; SMN2MEN1GAAKMT2ACYP1A2
SCHEMBL2093049 0.76 TSHR (0.46) SMN1; SMN2MEN1GAAKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925655-A NOVEL ISOINDOLONE DERIVATIVES FOR INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS AND CANCER DIABETIC RETINOPATHY AND OTHER DISEASES MERCK & CO., INC. (US) 1999-07-20 US disclosed